Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, February 13, 2018
[ Tue, Feb 13th 2018
] - WOPRAI
[ Tue, Feb 13th 2018
] - WOPRAI
[ Tue, Feb 13th 2018
] - WOPRAI
[ Tue, Feb 13th 2018
] - WOPRAI
Mon, February 12, 2018
[ Mon, Feb 12th 2018
] - WOPRAI
[ Mon, Feb 12th 2018
] - WOPRAI
[ Mon, Feb 12th 2018
] - WOPRAI
[ Mon, Feb 12th 2018
] - WOPRAI
[ Mon, Feb 12th 2018
] - WOPRAI
[ Mon, Feb 12th 2018
] - WOPRAI
[ Mon, Feb 12th 2018
] - WOPRAI
[ Mon, Feb 12th 2018
] - WOPRAI
[ Mon, Feb 12th 2018
] - WOPRAI
[ Mon, Feb 12th 2018
] - WOPRAI
[ Mon, Feb 12th 2018
] - WOPRAI
[ Mon, Feb 12th 2018
] - WOPRAI
[ Mon, Feb 12th 2018
] - WOPRAI
[ Mon, Feb 12th 2018
] - WOPRAI
[ Mon, Feb 12th 2018
] - WOPRAI
[ Mon, Feb 12th 2018
] - WOPRAI
[ Mon, Feb 12th 2018
] - WOPRAI
[ Mon, Feb 12th 2018
] - WOPRAI
Ken Trbovich Upgraded (CARA) to Strong Buy on, Feb 12th, 2018
Ken Trbovich of Janney Montgomery Scott, Upgraded "Cara Therapeutics, Inc." (CARA) to Strong Buy on, Feb 12th, 2018.
Ken has made no other calls on CARA in the last 4 months.
There is 1 other peer that has a rating on CARA. Out of the 1 peers that are also analyzing CARA, 0 agree with Ken's Rating of Hold.
This is the rating of the analyst that currently disagrees with Ken
- Corey Davis of "Seaport Global" Initiated at Strong Buy and Held Target at $27 on, Friday, January 19th, 2018
